Promimic makes implants integrate with HAnano Surface.
Promimic has developed a state-of-the-art nanotechnology that creates a unique bioactive surface on any implant. HAnano Surface is a 20 nanometer (.02 micrometer) thin implant surface treatment composed of crystalline hydroxyapatite (HA) particles, which have the same shape, composition, and structure as HA found in human bone. HAnano Surface has proven to accelerate bone growth in over 30 in vivo and in vitro studies. Faster and stronger osseointegration has been demonstrated through biomechanical, histomorphological, and biological evaluations, in combination with over 4000,000 clinical implantations to date.
Promimic operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, cardiothoracic, and sports medicine implant markets.
Promimic partners with medical device companies through all phases of product development and commercialization, including: initial feasibility and optimization, testing and regulatory submission, production setup and implementation, as well as launch and marketing support.
Brands: HAnano Surface up-regulates important bone marker proteins, enhances initial implant stability, improves osseointegration and promotes bone in-growth into porous materials and 3D-structures.